This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Well Known Stock Indices Worldwide gathers popular indices from different continents. Use this global snapshot to gauge market health.
21,921 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
As Zymeworks gears up for 2026 earnings, investors should focus on cash runway, pipeline milestones, and collaboratio...
Snowflake beat estimates, raised its full-year outlook, and committed $6 billion to expand collaboration with AWS, se...
Dell Technologies rides an AI demand wave after strong quarterly results, fueling debate about whether the stock can ...
When a tech titan reshuffles its gaming division, investors pay attention. This article breaks down the potential sto...
Concentra's Q4 2025 results shed light on its growth engine and profitability. This article breaks down the numbers, ...
Fastly stock jumps 11% after a strong Q4 2025 report, fueling talk of a true comeback. Yet persistent insider selling...
Headlines grab attention, but smart investors verify. This guide shows how to validate headline phrasing editorial si...
Progressive and Lemonade sit at opposite ends of the insurance spectrum in 2026. This guide breaks down their models,...
FedEx reports earnings Tuesday, and traders want a clear take on demand, costs, and guidance. This guide breaks down ...
Palantir has cooled off after a blazing run, but analysts say there's still meaningful upside. This guide breaks down...
FMC Corporation has faced headwinds that can derail even strong portfolios. Here are two words that should make inves...